The gene GSTM2, instrumental in detoxifying substances, impacts the efficacy and toxicity of chemotherapy drugs like cisplatin and busulfan by influencing their metabolism. Cisplatin's side effects may be moderated by GSTM2, whereas busulfan's metabolism alterations can affect both its effectiveness and toxicity, stressing the importance of considering individual genetic differences in treatment plans.